OBF1 enhances transcriptional potential of Oct1

EMBO Journal

Volumn 22, Issue 9, 2003, Pages 2188-2198

  Lins, Katharina ^a   Reményi, Attila ^a,b   Tomilin, Alexey ^a   Massa, Steffen ^c   Wilmanns, Matthias ^b   Matthias, Patrick ^c   Schöler, Hans R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^c FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

Author keywords

Gene regulation; OBF1; POU; Transcription factor

Indexed keywords

DNA; OCTAMER TRANSCRIPTION FACTOR 1; OCTAMER TRANSCRIPTION FACTOR 2; RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; DNA BINDING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; NORTHERN BLOTTING; PLASMID; PRIORITY JOURNAL; PROTEIN PURIFICATION; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION;

B-LYMPHOCYTES; BASE SEQUENCE; BLOTTING, NORTHERN; CELL LINE; DIMERIZATION; DNA; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; MUTAGENESIS, SITE-DIRECTED; ORGANIC CATION TRANSPORTER 1; OSTEOPONTIN; POU DOMAIN FACTORS; SIALOGLYCOPROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0037544037     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/cdg199     Document Type: Article

References (36)

1. Babb, R., Cleary, M.A. and Herr, W. (1997) OCA-B is a functional analog of VP16 but targets a separate surface of the Oct-1 POU domain. Mol. Cell. Biol., 17, 7295-7305.
2. Bergman, Y., Rice, D., Grosschedl, R. and Baltimore, D. (1984) Two regulatory elements for immunoglobulin κ light chain gene expression. Proc. Natl Acad. Sci. USA, 81, 7041-7045.
3. Botquin, V., Hess, H., Fuhrmann, G., Anastassiadis, C., Gross, M.K., Vriend, G. and Schöler, H.R. (1998) New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2. Genes Dev., 12, 2073-2090.
4. Cepek, K.L., Chasman, D.I. and Sharp, P.A. (1996) Sequence-specific DNA binding of the B-cell-specific coactivator OCA-B. Genes Dev., 10, 2079-2088.
5. Chasman, D., Cepek, K., Sharp, P.A. and Pabo, C.O. (1999) Crystal structure of an OCA-B peptide bound to an Oct-1 POU domain/ octamer DNA complex: specific recognition of a protein-DNA interface. Genes Dev., 13, 2650-2657.
6. Denhardt, D.T., Butler, W.T., Chambers, A.F. and Senger D.R. (eds) (1995) Osteopontin: Role in Cell Signaling and Adhesion. New York Academy of Sciences, New York, NY.
7. Frauwirth, K.A. and Thompson, C.B. (2002) Activation and inhibition of lymphocytes by costimulation. J. Clin. Invest., 109, 295-299.
8. Gstaiger, M., Knoepfel, L., Georgiev, O., Schaffner,W. and Hovens, C.M. (1995) A B-cell coactivator of octamer-binding transcription factors. Nature, 373, 360-362.
9. Gstaiger, M., Georgiev, O., van Leeuwen, H., van der Vliet, P. and Schaffner, W. (1996) The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation. EMBO J., 15, 2781-2790.
10. Jacobson, E.M., Li, P., Leon-del-Rio, A., Rosenfeld, M.G. and Aggarwal, A.K. (1997) Structure of Pit-1 POU domain bound to DNA as a dimer: unexpected arrangement and flexibility. Genes Dev., 11, 198-212.
11. Kim, U., Qin, X.F., Gong, S., Stevens, S., Luo, Y., Nussenzweig, M. and Roeder, R.G. (1996) The B-cell-specific transcription coactivator OCA-B/OBF-1/Bob-1 is essential for normal production of immunoglobulin isotypes. Nature, 383, 542-547.
12. Klemm, J.D., Rould, M.A., Aurora, R., Herr, W. and Pabo, C.O. (1994) Crystal structure of the Oct-1 POU domain bound to an octamer site: DNA recognition with tethered DNA-binding modules. Cell, 77, 21-32.
13. Luo, Y. and Roeder, R.G. (1995) Cloning, functional characterization and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B. Mol. Cell. Biol., 15, 4115-4124.
14. Luo, Y., Fujii, H., Gerster, T. and Roeder, R.G. (1992) A novel B cell-derived coactivator potentiates the activation of immunoglobulin promoters by octamer-binding transcription factors. Cell, 71, 231-241.
15. Maciejewski, P.M., Peterson, F.C. Anderson, P.J. and Brooks, C.L. (1995) Mutation of serine 90 to glutamic acid mimics phosphorylation of bovine prolactin. J. Biol. Chem., 270, 27661-27665.
16. Marusic, A., Grcevic, D., Katavic, V., Kovacic, N., Lukic, I.K., Kalajzic, I. and Lorenzo, J.A. (2000) Role of B lymphocytes in new bone formation. Lab. Invest., 80, 1761-1774.
17. Nielsen, P.J., Georgiev, O., Lorenz, B. and Schaffner, W. (1996) B lymphocytes are impaired in mice lacking the transcriptional coactivator Bob1/OCA-B/OBF1. Eur. J. Immunol., 26, 3214-3218.
18. Nishimoto, M., Fukushima, A., Okuda, A. and Muramatsu, M. (1999) The gene for the embryonic stem cell coactivator UTF1 carries a regulatory element which selectively interacts with a complex composed of Oct-3/4 and Sox-2. Mol. Cell. Biol., 19, 5453-5465.
19. O'Regan, A. and Berman, J.S. (2000) Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation. Int. J. Exp. Pathol., 81, 373-390.
20. Reményi, A., Tomilin, A., Pohl, E., Lins, K., Philippsen, A., Reinbold, R., Schöler, H.R. and Wilmanns, M. (2001) Differential dimer activities of the transcription factor Oct-1 by DNA-induced interface swapping. Mol. Cell, 8, 569-580.
21. Rhee, J.M., Gruber, C.A., Brodie, T.B., Trieu, M. and Turner, E.E. (1998) Highly cooperative homodimerization is a conserved property of neural POU proteins. J. Biol. Chem., 273, 34196-34205.
22. Roberts, S.B., Segil, N. and Heintz, N. (1991) Differential phosphorylation of the transcription factor Oct1 during the cell cycle. Science, 253, 1022-1026.
23. Ryan, A.K. and Rosenfeld, M.G. (1997) POU domain family values: flexibility, partnerships and developmental codes. Genes Dev., 11, 1207-1225.
24. Sauter, P. and Matthias, P. (1998) Coactivator OBF-1 makes selective contacts with both the POU-specific domain and the POU homeodomain and acts as a molecular clamp on DNA. Mol. Cell. Biol., 18, 7397-7409.
25. Schöler, H.R., Balling, R., Hatzopoulos, A.K., Suzuki, N. and Gruss, P. (1989) Octamer binding proteins confer transcriptional activity in early mouse embryogenesis. EMBO J., 8, 2551-2557.
26. Schubart, D.B., Rolink, A., Kosco-Vilbois, M.H., Botteri, F. and Matthias, P. (1996) B-cell-specific coactivator OBF-1/OCA-B/Bob1 required for immune response and germinal centre formation. Nature, 383, 538-542.
27. Schubart, K., Massa, S., Schubart, D., Corcoran, L.M., Rolink, A.G. and Matthias, P. (2001) B cell development and immunoglobulin gene transcription in the absence of Oct-2 and OBF-1. Nat. Immunol., 2, 69-74.
28. Scully, K.M. et al. (2000) Allosteric effects of Pit-1 DNA sites on long-term repression in cell type specification. Science, 290, 1127-1131.
29. Segil, N., Roberts, S.B. and Heintz, N. (1991) Cell-cycle-regulated phosphorylation of the transcription factor Oct-1. Cold Spring Harb. Symp. Quant. Biol., 56, 285-292.
30. Staudt, L.M., Singh, H., Sen, R., Wirth, T., Sharp, P.A. and Baltimore, D. (1986) A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes. Nature, 323, 640-643.
31. Strubin, M., Newell, J.W. and Matthias, P. (1995) OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins. Cell, 80, 497-506.
32. Tomilin, A., Reményi, A., Lins, K., Bak, H., Leidel, S., Vriend, G., Wilmanns, M. and Schöler, H.R. (2000) Synergism with the coactivator OBF-1 (OCA-B, BOB-1) is mediated by a specific POU dimer configuration. Cell, 103, 853-864.
33. Verrijzer, C.P., Alkema, M.J., van Weperen, W.W., Van Leeuwen, H.C., Strating, M.J. and van der Vliet, P.C. (1992) The DNA binding specificity of the bipartite POU domain and its subdomains. EMBO J., 11, 4993-5003.
34. Weber, G.F. and Cantor, H. (1996) The immunology of Eta-1/osteopontin. Cytokine Growth Factor Rev., 7, 241-248.
35. Whitmarsh, A.J. and Davis, R.J. (2000) Regulation of transcription factor function by phosphorylation. Cell. Mol. Life Sci., 57, 1172-1183.
36. Yuan, H., Corbi, N., Basilico, C. and Dailey, L. (1995) Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev., 9, 2635-2645.